Memory decline evolves independently of disease activity in MS

Multiple Sclerosis

Volumn 14, Issue 7, 2008, Pages 947-953

  Duque, B ^a   Sepulcre, J ^a   Bejarano, B ^a   Samaranch, L ^a   Pastor, P ^a   Villoslada, Pablo ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Brief repeatable battery neuropsychology; Cognitive impairment; Longitudinal study; Multiple sclerosis; Selective reminding test; Symbol digit modality test

Indexed keywords

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL EVALUATION; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DISABILITY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; MEMORY DISORDER; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; PROSPECTIVE STUDY; RATING SCALE; RELAPSE; VERBAL MEMORY; COGNITIVE DEFECT; LONGITUDINAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE;

ADULT; COGNITION DISORDERS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY DISORDERS; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PROSPECTIVE STUDIES;

EID: 54449092493     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508089686     Document Type: Article

References (39)

1. Rao SM. Neuropsychology of multiple sclerosis. Curr Opin Neurol 1995; 8: 216-220.
2. Sepulcre J Vanotti S Hernandez R. Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test. Mult Scler 2006; 12: 187-195.
3. Rothwell PM McDowell Z Wong CK Dorman PJ. Doctors and patients don't agree: Cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ 1997; 314: 1580-1583.
4. Benito-Leon J Morales JM Rivera-Navarro J. Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur J Neurol 2002; 9: 497-502.
5. Beatty WW Goodkin DE Hertsgaard D Monson N. Clinical and demographic predictors of cognitive performance in multiple sclerosis. Do diagnostic type, disease duration, and disability matter? Arch Neurol 1990; 47: 305-308.
6. Camp SJ Stevenson VL Thompson AJ. A longitudinal study of cognition in primary progressive multiple sclerosis. Brain 2005; 128: 2891-2898.
7. Amato MP Ponziani G Siracusa G Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Arch Neurol 2001; 58: 1602-1606.
8. Amato MP Zipoli V Portaccio E. Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies. J Neurol Sci 2006; 245: 41-46.
9. Thomas PW Thomas S Hillier C Galvin K Baker R. Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev 2006; CD004431.
10. Amato MP Portaccio E Zipoli V. Are there protective treatments for cognitive decline in MS? J Neurol Sci 2006; 245: 183-186.
11. Krupp LB Christodoulou C Melville P Scherl WF MacAllister WS Elkins LE. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 2004; 63: 1579-1585.
12. Polman CH Reingold SC Edan G. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846.
13. Oldfield RC. The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia 1971; 9: 97-113.
14. Cummings JL. The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology 1997; 48: S10-S16.
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
16. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55.
17. Sepulcre J Murie-Fernandez M Salinas-Alaman A Garcia-Layana A Bejarano B Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007; 68: 1488-1494.
18. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
19. Fischer JS Rudick RA Cutter GR Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): An integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999; 5: 244-250.
20. Rio J Nos C Tintore M. Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients. Ann. Neurol 2006; 59: 344-352.
21. Koch W Ehrenhaft A Griesser K Peufer A Muller J Schomig A. Taqman systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clin Chem Lab Med 2002; 40: 1123-1131.
22. Koutsis G Panas M Giogkaraki E. APOE epsilon4 is associated with impaired verbal learning in patients with MS. Neurology 2007; 68: 546-549.
23. Hauser SL Oksenberg JR. The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration. Neuron 2006; 52: 61-76.
24. Pirko I Lucchinetti CF Sriram S Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 2007; 68: 634-642.
25. Audoin B Davies GR Finisku L Chard DT Thompson AJ Miller DH. Localization of grey matter atrophy in early RRMS: A longitudinal study. J Neurol 2006; 253: 1495-1501.
26. Glanz BI Holland C Gauthier SA. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler 2007; 13: 1004-1010.
27. de Sonneville LM Boringa JB Reuling IE Lazeron RH Ader HJ Polman CH. Information processing characteristics in subtypes of multiple sclerosis. Neuropsychologia 2002; 40: 1751-1765.
28. Kujala P Portin R Ruutiainen J. The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain 1997; 120: 289-297.
29. Ruggieri RM Palermo R Vitello G Gennuso M Settipani N Piccoli F. Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS ≤3.5. Acta Neurol Scand 2003; 108: 323-326.
30. Bergendal G Fredrikson S Almkvist O. Selective decline in information processing in subgroups of multiple sclerosis: An 8-year longitudinal study. Eur Neurol 2007; 57: 193-202.
31. Huijbregts SC Kalkers NF de Sonneville LM de Groot V Reuling IE Polman CH. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 2004; 63: 335-339.
32. Huijbregts SC Kalkers NF de Sonneville LM de Groot V Polman CH. Cognitive impairment and decline in different MS subtypes. J Neurol Sci 2006; 245: 187-194.
33. Piras MR Magnano I Canu ED. Longitudinal study of cognitive dysfunction in multiple sclerosis: Neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry 2003; 74: 878-885.
34. Patti F Failla G Ciancio MR L'Episcopo MR Reggio A. neuropsychological, neuroradiological and clinical findings in multiple sclerosis. A 3 year follow-up study. Eur J Neurol 1998; 5: 283-286.
35. Zivadinov R Sepcic J Nasuelli D. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001; 70: 773-780.
36. Denney DR Lynch SG Parmenter BA. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: Speed matters. J Neurol Sci 2007; 267(1-2): 129-136.
37. Jennekens-Schinkel A Laboyrie PM Lanser JB van der Velde EA. Cognition in patients with multiple sclerosis after four years. J Neurol Sci 1990; 99: 229-247.
38. Mariani C Farina E Cappa SF. Neuropsychological assessment in multiple sclerosis: A follow-up study with magnetic resonance imaging. J Neurol 1991; 238: 395-400.
39. Schwid SR Goodman AD Weinstein A McDermott MP Johnson KP. Cognitive function in relapsing multiple sclerosis: Minimal changes in a 10-year clinical trial. J Neurol Sci 2007; 255: 57-63.